Korean J Gynecol Endosc Minim Invasive Surg.  2012 Nov;24(2):77-83.

Prognostic factors in early endometrial cancer: a single institution

Affiliations
  • 1Department of Obstetrics and Gynecology, Inha University College of Medicine, Incheon, Korea.
  • 2Department of Pathology, Inha University College of Medicine, Incheon, Korea.

Abstract


OBJECTIVE
To assess the prognostic factors of early endometrial cancer.
METHODS
Medical records of patients with endometrial cancer stage I and II were reviewed retrospectively between 1999 and 2005. Progress-free survival rates of each prognostic factor were obtained.
RESULTS
The mean age of 45 patients was 49 (27-74). Thirty-nine patients had stage I, 6 patients had stage II of the disease. Most cases of histology were diagnosed with endometrioid adenocarcinoma (42 patients, 93.3%). Twenty-three patients had grade 1, 16 patients had grade 2, and 6 patients had grade 3 histology. Thirty patients had myometrial invasion of less than 50%, while 15 patients had myometrial invasion of more than 50%. Thirty-one patients showed no lympho-vascular space involvement (LVSI), and 14 patients were LVSI positive. All patients were primarily treated by surgery. Twenty-four patients received adjuvant radiotherapy, and 1 patient received concurrent chemotherapy and radiotherapy. In univariate analysis, FIGO stage (p=0.004), tumor grade (p=0.043), myometrial invasion (p=0.030), and LVSI (p=0.003) had statistical significance with PFSR. However, age, parity, menopause, lymphadenectomy, and histology did not.
CONCLUSION
Stage, tumor grade, myometrial invasion, and LVSI seemed to be statistical prognostic factors in early endometrial cancer.

Keyword

Endometrial cancer; Prognostic factor; Progress-free survival rate

MeSH Terms

Carcinoma, Endometrioid
Endometrial Neoplasms
Female
Humans
Lymph Node Excision
Medical Records
Menopause
Parity
Radiotherapy, Adjuvant
Retrospective Studies
Survival Rate
Full Text Links
  • KJGEMIS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr